Literature DB >> 6256667

Complete blockade by phenoxybenzamine of alpha 1- but not of alpha 2-vascular receptors in dogs and the effects of propranolol.

J W Constantine, W Lebel.   

Abstract

In pithed dogs pressor responses to phenylephrine were completely inhibited 1 h after phenoxybenzamine 20 mg/kg i.v., but those to norepinephrine were only partially inhibited. The pressor effects of norepinephrine in phenoxybenzamine-treated animals were inhibited by yohimbine, 2.0 mg/kg i.v., but not by prazosin, 0.5 mg/kg i.v. In animals treated with phenoxybenzamine, 20 mg/kg i.v., plus propranolol, 5.0 mg/kg i.v., the partially restored pressor response to epinephrine, and the responses to norepinephrine, were completely inhibited by yohimbine, 2.0 mg/kg i.v., partially inhibited by corynanthine, 5.0 mg/kg i.v., but not affected by prazosin, 0.5 mg/kg i.v. In additional animals treated with phenoxybenzamine plus propranolol, yohimbine, 10, 50, 200 and 500 microgram/kg i.v., caused dose-related inhibition of both the partially restored pressor response to epinephrine, and the pressor responses to norepinephrine. It is concluded that: 1) phenoxybenzamine completely blocks alpha 1, but not alpha 2 vascular receptors; 2) the pressor effect of norepinephrine in phenoxybenzamine-treated animals, and the partially restored pressor effect of epinephrine in phenoxybenzamine-propranolol-treated animals, are both mediated by alpha 2 vascular receptors which are resistant to blockade by phenoxybenzamine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6256667     DOI: 10.1007/bf00504531

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Reversal of adrenergic vasodepression.

Authors:  W OSSWALD
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-07-01

2.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

3.  Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine.

Authors:  K Starke; E Borowski; T Endo
Journal:  Eur J Pharmacol       Date:  1975-12       Impact factor: 4.432

4.  Effects of the beta adrenergic blocking agents, propranolol, KO592, and MJ-1999 on phenoxybenzamine blockade of norepinephrine.

Authors:  R D Smith; C B Nash
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-09

5.  The reversal of phenoxybenzamine-produced alpha-adrenoceptor blockade by the isomers of propranolol and INPEA.

Authors:  W G Davis
Journal:  J Pharm Pharmacol       Date:  1971-05       Impact factor: 3.765

6.  Effects of pronethalol on the cardiovascular actions of catecholamines during blockade by phenoxybenzamine.

Authors:  J Garrett; A Malafaya-Baptista; W Osswald
Journal:  Br J Pharmacol Chemother       Date:  1966-09

7.  Steric aspects of adrenergic drugs. XI. Interactions of dibenamine and beta adrenergic blockers.

Authors:  P N Patil; A Tye; C May; S Hetey; S Miyagi
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

8.  Effect of propranolol on alpha-adrenergic blockade in the dog and isolated rabbit aortic strip.

Authors:  G J Olivares; N T Smith; L Aronow
Journal:  Br J Pharmacol Chemother       Date:  1967-06

9.  Reversal by pronethalol of dibenamine blockade: a study on the seminal vesicle of the guinea-pig.

Authors:  S Guimarães
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

10.  Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.

Authors:  G M Drew; S B Whiting
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

View more
  15 in total

1.  Postjunctional alpha-adrenoceptors in the isolated saphenous vein of the rabbit. Characterization and influence of angiotensin.

Authors:  H J Schümann; I Lues
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

2.  Regional variation in the alpha-adrenergic receptors in the canine resistance vessels.

Authors:  P T Horn; J D Kohli; J J Listinsky; L I Goldberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

3.  Inhibition of vasoconstriction to cirazoline by calcium-entry blockade after phenoxybenzamine in rat perfused hindquarters.

Authors:  C Korstanje; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

4.  Smooth muscle of rabbit aorta contains alpha 1-but not alpha 2-adrenoceptors.

Authors:  J R Docherty; J W Constantine; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

5.  Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.

Authors:  C A Hamilton; J L Reid; J Vincent
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

Review 6.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

7.  The recovery of alpha-adrenoceptor function and binding sites after phenoxybenzamine. An index of receptor turnover?

Authors:  C A Hamilton; H W Dalrymple; J L Reid; D J Sumner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

8.  Facilitating interaction between rauwolscine and angiotensin in the mesenteric artery of the rabbit.

Authors:  I Lues; R Vinke; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

9.  Differential blockade of alpha-adrenoceptors by indoramin.

Authors:  D P Nicholls; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

10.  An examination of the pre- and postsynaptic alpha-adrenoceptors involved in neuroeffector transmission in rabbit aorta and portal vein.

Authors:  J R Docherty; K Starke
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.